Where does Invoy Holdings Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Invoy Holdings Inc. ranks #8,413 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Invoy Holdings Inc. hold?

Invoy Holdings Inc. holds 38 US utility patents granted between 2018 and 2024, spanning 13 technology areas.

What is Invoy Holdings Inc.'s Innovation Score?

Invoy Holdings Inc. has an Innovation Score of 42.3 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Invoy Holdings Inc. focus on?

Invoy Holdings Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 31 patents, ranking #603 of 7,127 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Invoy Holdings Inc.'s patent grant rate increasing or decreasing?

Invoy Holdings Inc.'s recent grant velocity is +180% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Invoy Holdings Inc.'s patents?

Invoy Holdings Inc.'s patents average 17.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Invoy Holdings Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Invoy Holdings Inc.

USPTO PatentsView assignee record - 38 granted patents across 13 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Invoy ranks #8,413 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 13 technology areas.

#8,413
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.3/100): 17.7
avg claims per patent: +180%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8413 · US Corporation #8,413 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,413/49,997
PHOTO-FINISH Idenix Pharmaceuticals
CPC-FOCUS A61B · 13 areas
INNOV-PAR 42.3/100
CLAIMS-RICH 17.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +180% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Idenix Pharmaceuticals LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Invoy’s 42.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (30%) Velocity 6.3 pts (15%) Breadth 12.7 pts (30%) Claim depth 10.6 pts (25%)

Qualcomm Incorporated · highest

85
QSC · near

42
Erasmus University… · near

42
Invoy Holdings · this assignee

42
Nagasaki University · near

42
SAP Portals Israel · near

42
3D Lighting… · lowest

7

What this shows Invoy's Innovation Score is 42.3/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Invoy?

Each dot is one of Invoy’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Invoy’s own 17.7 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Invoy vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Invoy's grants concentrate

Invoy Holdings Inc. is a focused PatentsView assignee: 13 CPC subclasses with 81.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (10 grants) versus a trough of 1 in 2018. By volume, Invoy sits between Idenix Pharmaceuticals LLC and Juluen Enterprise Co., Ltd..

Invoy's three-year grant acceleration

Invoy Holdings Inc. shows 18 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Idenix Pharmaceut…

38
Ikanos Communicat…

38
Intelmate

38
Intermetro Indust…

38
Jamco

38
Jemella

38
Jiangnan Environm…

38
Juluen Enterprise

38
Invoy Holdings ◀

38

What this shows Invoy holds 38 patents at rank #8,415, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Invoy

By rank, the assignees closest to #8,415 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Invoy's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Invoy, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Invoy ranks #603 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Nagasaki University 42 Erasmus University Medical Center Rotterdam 42 SAP Portals Israel Ltd 42 QSC, LLC 42

Invoy's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Invoy Holdings Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	2.6%
2019	9	23.7%
2020	8	21.1%
2021	2	5.3%
2022	6	15.8%
2023	10	26.3%
2024	2	5.3%

Which technologies does Invoy Holdings Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 31

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 23

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 9

G06F - Electric Digital Data Processing 7

H04W - Wireless Communication Networks 6

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 5

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 5

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 4

Y10T - Technical Subjects Covered BY Former US Classification 3

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

G06N - Computing Arrangements Based ON Specific Computational Models 2

H04M - Telephonic Communication 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Invoy Holdings Inc.'s patent record in context - here's where to go next.

Invoy Holdings Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 81.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #8,413 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Invoy Holdings Inc. against Idenix Pharmaceuticals LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.